Arcadia Biosciences, Inc. Contracts & Agreements
109 Contracts & Agreements
- Business Finance (55 contracts)
- Business Operations (3)
- Human Resources (24)
- Intellectual Property (8)
- Real Estate (3)
- Uncategorized (16)
- Employment Letter and Severance and Change In Control Agreement for Thomas J. Schaefer (Filed With SEC on August 23, 2024)
- Employment Letter and Severance and Change In Control Agreement for Mark Kawakami (Filed With SEC on August 23, 2024)
- 2015 Omnibus Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on August 13, 2024)
- Separation Agreement for Stanley Jacot Jr (Filed With SEC on July 8, 2024)
- Asset Purchase Agreement (Filed With SEC on May 20, 2024)
- Promissory Note (Filed With SEC on May 20, 2024)
- Security Agreement (Filed With SEC on May 20, 2024)
- Asset Purchase Agreement (Filed With SEC on May 17, 2024)
- Description of Registrants Securities Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 28, 2024)
- Separation Agreement for Laura Pitlik (Filed With SEC on February 14, 2024)
- Employment Letter and Severance and Change In Control Agreement for Thomas J. Schaefer (Filed With SEC on January 5, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on August 16, 2022)
- Form of Preferred Investment Option (Filed With SEC on August 16, 2022)
- Form of Placement Agent Preferred Investment Option (Filed With SEC on August 16, 2022)
- Form Securities Purchase Agreement (Filed With SEC on August 16, 2022)
- Employment letter for Stanley E. Jacot, Jr., Chief Executive Officer (Filed With SEC on May 12, 2022)
- Severance and Change In Control Agreement for Chris Cuvelier (Filed With SEC on March 31, 2022)
- Severance Agreement (Filed With SEC on February 7, 2022)
- Inducement Option Grant for Stanley Jacot (Filed With SEC on February 7, 2022)
- Separation and Release Agreement (Filed With SEC on December 20, 2021)
- Severance and Change In Control Agreement for Laura Pitlik (Filed With SEC on November 15, 2021)
- Transition Agreement (Filed With SEC on September 7, 2021)
- Employment letter for Chris Cuvelier, Chief Growth Officer (Filed With SEC on August 16, 2021)
- Asset Purchase Agreement dated May 17, 2021, by and among Arcadia, Buyer, Seller, Eko, Lief, Zola and Parent (Filed With SEC on May 21, 2021)
- Inducement Option Grant for Chris Cuvelier (Filed With SEC on May 21, 2021)
- Form of Investor Warrant (Filed With SEC on January 29, 2021)
- Form of Placement Agent Warrant (Filed With SEC on January 29, 2021)
- Form of Securities Purchase Agreement dated as of January 25, 2021, between Arcadia Biosciences, Inc. and each purchaser named on the signature pages thereto (Filed With SEC on January 29, 2021)
- Form of Registration Rights Agreement dated as of January 25, 2021, between Arcadia Biosciences, Inc. and each purchaser named on the signature pages thereto (Filed With SEC on January 29, 2021)
- Form of Investor Warrant (Filed With SEC on December 22, 2020)
- Form of Placement Agent Warrant (Filed With SEC on December 22, 2020)
- Form of Securities Purchase Agreement dated as of December 18, 2020, between Arcadia Biosciences, Inc. and each purchaser named on the signature pages thereto (Filed With SEC on December 22, 2020)
- Master Transaction Agreement (Filed With SEC on December 22, 2020)
- Amendment No. 9 to the Office Lease dated March 17, 2003 between the Registrant and Pac West Office Equities, LP (Filed With SEC on August 13, 2020)
- Form of New Warrant issued on July 8, 2020 (Filed With SEC on July 8, 2020)
- Form of Placement Agent Warrant issued on July 8, 2020 (Filed With SEC on July 8, 2020)
- Form of Letter Agreement, dated as of July 6, 2020 (Filed With SEC on July 8, 2020)
- Loan Agreement, dated May 18, 2020, by and between MidFirst Bank and Arcadia Biosciences, Inc (Filed With SEC on July 2, 2020)
- Pledge and Security Agreement dated May 18, 2020, by and between MidFirst Bank and Arcadia Biosciences, Inc (Filed With SEC on July 2, 2020)
- Promissory Note, dated June 26, 2020, by and between MidFirst Bank and Arcadia Biosciences, Inc (Filed With SEC on July 2, 2020)
- Form of New Warrant issued on May 18, 2020 (Filed With SEC on May 18, 2020)
- Form of Placement Agent Warrant issued on May 18, 2020 (Filed With SEC on May 18, 2020)
- Form of Letter Agreement, dated as of May 14, 2020 (Filed With SEC on May 18, 2020)
- Promissory Note, dated April 16, 2020, by and between MidFirst Bank and Arcadia Biosciences, Inc (Filed With SEC on April 21, 2020)
- Description of Registrant's Securities Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 25, 2020)
- Amendment No. 8 to the Office Lease dated March 17, 2003 between the Registrant and Pac West Office Equities, LP (Filed With SEC on March 25, 2020)
- Form of Warrant (Filed With SEC on September 9, 2019)
- Form of Placement Agent Warrant (Filed With SEC on September 9, 2019)
- Form of Securities Purchase Agreement dated as of September 5, 2019, between Arcadia Biosciences, Inc. and each purchaser named in the signature pages thereto (Filed With SEC on September 9, 2019)
- Separation and Release Agreement for Rajendra Ketkar, dated as of August 23, 2019 (Filed With SEC on August 28, 2019)
- Limited Liability Company Operating Agreement for Archipelago Ventures Hawaii, LLC, dated as of August 9, 2019 (Filed With SEC on August 9, 2019)
- 2015 Omnibus Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on July 26, 2019)
- Offer Letter and appended form of Severance and Change In Control Agreement between the Registrant and Sarah Reiter, dated February 16, 2018 (Filed With SEC on July 26, 2019)
- Form of Warrant (Filed With SEC on June 14, 2019)
- Form of Placement Agent Warrant (Filed With SEC on June 14, 2019)
- Form of Securities Purchase Agreement dated as of June 12, 2019, between Arcadia Biosciences, Inc. and each purchaser named in the signature pages thereto (Filed With SEC on June 14, 2019)
- Amended and Restated 2015 Omnibus Equity Incentive Plan (Filed With SEC on June 7, 2019)
- Office Lease dated March 17, 2003 between the Registrant and Buzz Oates LLC as successor to Marvin L. Oates, Trustee of the Marvin L. Oates Trust, as amended (Filed With SEC on December 27, 2018)
- Form of Warrant (Filed With SEC on June 14, 2018)
- Form of Placement Agent Warrant (Filed With SEC on June 14, 2018)
- Form of Securities Purchase Agreement dated as of June 11, 2018, between Arcadia Biosciences, Inc. and each purchaser named in the signature pages thereto (Filed With SEC on June 14, 2018)
- Form of Warrant (Filed With SEC on March 23, 2018)
- Securities Purchase Agreement dated as of March 19, 2018, between Arcadia Biosciences, Inc. and each purchaser named in the signature pages thereto (Filed With SEC on March 23, 2018)
- Form of Registration Rights Agreement (Filed With SEC on March 23, 2018)
- 202 Cousteau Place Suite 105 Davis, CA 95618 Tel: 530 ###-###-#### Fax: 530 ###-###-#### Web: www.arcadiabio.com (Filed With SEC on November 10, 2016)
- Strike Price* (Filed With SEC on September 8, 2016)
- 202 Cousteau Place Suite 105 Davis, CA 95618 Tel: 530 ###-###-#### Fax: 530 ###-###-#### Web: www.arcadiabio.com (Filed With SEC on August 9, 2016)
- AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY (Filed With SEC on May 10, 2016)
- 202 Cousteau Place Suite 105 Davis, CA 95618 Tel: 530 ###-###-#### Fax: 530 ###-###-#### Web: www.arcadiabio.com (Filed With SEC on May 10, 2016)
- 202 Cousteau Place Suite 105 Davis, CA 95618 Tel: 530 ###-###-#### Fax: 530 ###-###-#### Web: www.arcadiabio.com (Filed With SEC on February 12, 2016)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on December 30, 2015)
- FIRST AMENDMENT TO LOANAND SECURITY AGREEMENT (Filed With SEC on August 11, 2015)
- DIRECTOR COMPENSATION POLICY (Filed With SEC on June 25, 2015)
- INTELLECTUAL PROPERTY LICENSE AGREEMENT (Filed With SEC on June 10, 2015)
- ARCADIA BIOSCIENCES, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN (Approved by the Board April 28, 2015) (Filed With SEC on May 11, 2015)
- ARCADIA BIOSCIENCES, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Approved by the Board April 28, 2015) (Filed With SEC on May 11, 2015)
- ARCADIA BIOSCIENCES, INC. EXECUTIVE INCENTIVE BONUS PLAN (Adopted by the Board of Directors on April 28, 2015 and effective as of immediately prior to the effectiveness of the... (Filed With SEC on May 11, 2015)
- DIRECTOR COMPENSATION POLICY (Filed With SEC on May 11, 2015)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on April 30, 2015)
- AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 30, 2015)
- AMENDED AND RESTATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 30, 2015)
- AMENDED & RESTATED STOCK PURCHASE WARRANT ARCADIA BIOSCIENCES, INC. (Filed With SEC on April 30, 2015)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on April 30, 2015)
- [Insert Number of Shares] Arcadia Biosciences, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 6, 2015)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on April 6, 2015)
- INTELLECTUAL PROPERTY LICENSE AGREEMENT (Filed With SEC on April 6, 2015)
- EXCLUSIVE LICENSE AGREEMENT BETWEEN ARCADIA BIOSCIENCES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR DROUGHT-RESISTANT PLANTS (Filed With SEC on April 6, 2015)
- AMENDED AND RESTATED LICENSE AGREEMENT Between ROSS PRODUCTS DIVISION OF ABBOTT LABORATORIES And ARCADIA BIOSCIENCES, INC. Dated JULY 25, 2007 (Filed With SEC on April 6, 2015)
- 202 Cousteau Place Suite 200 Davis, CA 95618 Tel: 530 ###-###-#### Fax: 530 ###-###-#### Web: www.arcadiabio.com (Filed With SEC on April 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on April 6, 2015)
- 202 Cousteau Place Suite 200 Davis, CA 95618 Tel: 530 ###-###-#### Fax: 530 ###-###-#### Web: www.arcadiabio.com (Filed With SEC on April 6, 2015)
- ARCADIA BIOSCIENCES, INC. INVESTORS RIGHTS AGREEMENT March 28, 2014 (Filed With SEC on February 17, 2015)
- ARCADIA BIOSCIENCES, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on February 17, 2015)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on February 17, 2015)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 17, 2015)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 17, 2015)
- STOCK PURCHASE WARRANT ARCADIA BIOSCIENCES, INC. (Filed With SEC on February 17, 2015)
- ARCADIA BIOSCIENCES INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on February 17, 2015)
- LICENSE AGREEMENT (Filed With SEC on February 17, 2015)
- INTELLECTUAL PROPERTY LICENSE AGREEMENT (Filed With SEC on February 17, 2015)
- EXCLUSIVE LICENSE AGREEMENT BETWEEN ARCADIA BIOSCIENCES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR DROUGHT-RESISTANT PLANTS (Filed With SEC on February 17, 2015)
- ASSIGNMENT AND ASSUMPTION OF CONTRACT (Filed With SEC on February 17, 2015)
- AMENDED AND RESTATED LICENSE AGREEMENT Between ROSS PRODUCTS DIVISION OF ABBOTT LABORATORIES And ARCADIA BIOSCIENCES, INC. Dated JULY 25, 2007 (Filed With SEC on February 17, 2015)
- COLLABORATIVE RESEARCH & DEVELOPMENT AGREEMENT (Filed With SEC on February 17, 2015)
- ARCADIA BIOSCIENCES, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on February 17, 2015)
- ARCADIA BIOSCIENCES, INC. 2006 STOCK PLAN (as Amended and Restated On May 4, 2012) (Filed With SEC on February 17, 2015)
- ARCADIA BIOSCIENCES, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN (Filed With SEC on February 17, 2015)
- ARCADIA BIOSCIENCES, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on February 17, 2015)
- TERM LOAN AGREEMENT (Filed With SEC on February 17, 2015)